
    
      The objective of this protocol is to provide diagnosis and follow Experimental Therapeutics
      Branch (ETB) patients not currently entered on another research protocol. No investigational
      treatments will be administered on this protocol, and the NIH physicians will be playing
      largely a consultative role to the patient's primary physician.
    
  